Volitionrx limited announces closing of $8.7 million underwritten public offering of common stock

Henderson, nevada , feb. 22, 2023 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company, announced today the closing of its previously announced underwritten public offering of 4,945,000 shares of its common stock, including the exercise in full of the underwriter's overallotment option, at a public offering price of $1.75 per share. the gross proceeds to volition from the offering, before deducting underwriting commissions and other offering expenses payable by volition, were approximately $8.7 million.
VNRX Ratings Summary
VNRX Quant Ranking